A Piezo1 agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

KC159

Item No. 43640

Technical Information
Formal Name
4-(5-((2,6-dichlorobenzyl)thio)-1,3,4-thiadiazol-2-yl)benzoic acid
Molecular Formula
C16H10Cl2N2O2S2
Formula Weight
Purity
≥98%
Formulation
A solid
Acetonitrile: Slightly soluble: 0.1-1 mg/mlDMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
O=C(O)C1=CC=C(C2=NN=C(SCC3=C(Cl)C=CC=C3Cl)S2)C=C1
InChi Code
InChI=1S/C16H10Cl2N2O2S2/c17-12-2-1-3-13(18)11(12)8-23-16-20-19-14(24-16)9-4-6-10(7-5-9)15(21)22/h1-7H,8H2,(H,21,22)
InChi Key
KFIUJWYVLYQUOY-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    KC159 is an agonist of Piezo1.1 It induces calcium influx in HEK cells overexpressing mouse Piezo1 (EC50 = 280 nM) and induces inward currents in a whole-cell patch-clamp assay using HEK cells overexpressing mouse Piezo1 when used at a concentration of 10 µM. KC159 induces smooth muscle relaxation in isolated and perfused mouse portal veins (EC50s = 1.14 µM).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Parsonage, G., Cuthbertson, K., Endesh, N., et alImproved PIEZO1 agonism through 4-benzoic acid modification of Yoda1. Br. J. Pharmacol. 180(16), 2039-2063 (2023).